← Dashboard

Matthew Thomas J Halma

Open Source Medicine
Biophysics
CiteVector
Citation report
October 31, 2026

1. Summary

Matthew Thomas J Halma is a researcher affiliated with Open Source Medicine, working in biophysics. Since 2019, they have published 44 works, accumulating 558 citations, an h-index of 14, and an i10-index of 16. Among all active authors with 10 or more works in their core topics, Halma’s h-index places them in the top 28% for SARS-CoV-2 research, top 33% for force microscopy, and top 39% for RNA and protein synthesis mechanisms. Citation ranks are top 46%, top 47%, and 42nd percentile, respectively. Self-citation accounts for 9% of total citations.

558
Citations
540 since 2021
14
h-index
14 since 2021
16
i10-index
44
Publications
since 2019
155
Citations in 2025
+74% vs 2024
66%
Growth per year
over 1 observed year
Top 28%
h-index among peers
of 99,852 active SARS-CoV-2 and COVID-19 Research authors
Key findings
  • 155 citations were received in 2025, an increase of 74% on 2024.
  • Total citations grew at about 66% per year over the 1 year covered by archived captures of the profile.
  • The h-index ranks in the top 28% of 99,852 active SARS-CoV-2 and COVID-19 Research authors in OpenAlex, and in the 12th percentile among 15,745 authors with a similar number of works (a more senior group).
  • 378 papers cite the 50 most-cited works, from authors in 71 countries and more than 200 institutions.
  • 90.6% of citing papers are independent of the researcher (self-citation share 9.4%).
  • Halma is first author on 57% and last author on 13% of 83 indexed works, with 91 distinct co-authors at 37 institutions.
  • 94% of indexed works are open access.
  • 16 of 44 papers have at least 10 citations and 0 have 100 or more; the top five papers account for 46% of all citations.
  • The model projects an h-index of 21 by 2029 and 23 by 2031 from the existing papers alone.

2. Citation trajectory

Halma’s citation record shows accelerating growth. Yearly citations rose from 14 in 2020 to 188 in 2026, with a compound annual growth rate of 66% over the observed period. Between October 2025 and October 2026, total citations increased from 329 to 558, the h-index from 11 to 14, and the i10-index from 11 to 16. Milestones reached include 100 and 250 citations by October 2025, and 500 citations by October 2026. The h-index is projected to reach 15 by 2027. This trajectory reflects a rapid uptake of the researcher’s work.

02004006002026Jul 2026Total citations
Total citations on each dated observation: Wayback Machine captures (amber), CiteVector observations (green) and the live value (blue).
050100150200Citations per year2020202120222023202420252026
Citations received per year as reported by the profile; the current year is partial.

3. Index trajectory and milestones

051015202026Jul 2026Index valueh-indexi10-index
h-index and i10-index at each dated observation of the profile.
MilestoneReachedSource
h-index 5by Oct 2025already reached at the earliest observation
h-index 10by Oct 2025already reached at the earliest observation
100 citationsby Oct 2025already reached at the earliest observation
250 citationsby Oct 2025already reached at the earliest observation
500 citationsOct 2026first observation at or above this level
h-index 152027 (projected)year-end projection from existing papers (section 7)
h-index 202029 (projected)year-end projection from existing papers (section 7)
1,000 citations2029 (projected)year-end projection from existing papers (section 7)

4. Standing among peers

Percentiles are computed exactly from OpenAlex counts, not samples, for each of the researcher's main topics and for two peer groups: all active authors in the topic (at least 10 works), the population a committee usually has in mind, and authors with similar output (between 56 and 226 works, half to double this researcher's 113 in OpenAlex), a strict control for career stage that leans towards senior researchers because OpenAlex counts preprints and versions as works. The percentile is the share of the group ranking below the researcher. Everyone, including this researcher (OpenAlex h-index 13, 457 citations), is measured with OpenAlex's own figures, so the comparison is like for like.

0th25th50th75th100thSARS-CoV-2 and COVID-19 Researchall active authors (10+ works)99,852 peersh-index 72thcitations 54thSARS-CoV-2 and COVID-19 Researchsimilar output (56–226 works)15,745 peersh-index 12thcitations 8thForce Microscopy Techniques and Applicat…all active authors (10+ works)15,958 peersh-index 67thcitations 53thForce Microscopy Techniques and Applicat…similar output (56–226 works)3,328 peersh-index 13thcitations 10thRNA and protein synthesis mechanismsall active authors (10+ works)38,774 peersh-index 61thcitations 42thRNA and protein synthesis mechanismssimilar output (56–226 works)7,303 peersh-index 7thcitations 5th
Percentile rank for h-index (blue) and total citations (green) in each topic, for both peer groups.
MeasureGoogle ScholarOpenAlexNote
Citations558457Scholar indexes more sources (preprints, theses, books), so it runs higher
h-index1413Percentiles above use the OpenAlex value
i10-index1614
Publications44113OpenAlex may split or merge author records; see the OpenAlex ID in section 9
Self-citation share—9.4%35 of 373 citing papers include the researcher as an author (covering the 40 most-cited papers). Shares under 15% are typical.

5. Who cites this work

Every paper in OpenAlex that cites one of the 50 most-cited works was counted by the country and institution of its authors, by venue and by year. Counts are of citing papers, so a paper with authors in two countries counts once for each.

378
Citing papers
in OpenAlex
71
Countries
led by China
200+
Institutions
led by University of Alberta
91%
Independent
citing papers without the researcher as author
110
Citing papers in 2025
108 so far in 2026
China100United States91Canada33India24Germany23United Kingdom23Netherlands21Italy17Spain15Estonia12
Citing papers by author country (top 10 of 71).
University of Alberta23Independent Medical All…13Vrije Universiteit Amst…11Open Source Medicine Fo…10Helmholtz Association o…9Chinese Academy of Scie…9University of Maryland,…9University of Cambridge8New York University8Centre National de la R…7
Citing papers by author institution (top 10).
050100150Citing papers20192020202120222023202420252026
Citing papers published per year (current year partial).
bioRxiv (Cold Spring Ha…13Nucleic Acids Research12Viruses10Preprints.org10International Journal o…6Proceedings of the Nati…6Frontiers in Immunology6Nature Communications6
Venues that cite the work most often.

By document type: article 213 · review 106 · preprint 38 · book-chapter 8 · conference-paper 4.

6. Publication portfolio

Halma’s 44 publications span five themes: mRNA Vaccine Frameshifting and Public Trust (26 papers, 137 citations), Force Spectroscopy of DNA-Protein Interactions (15, 121), Spike Protein Injury and Therapeutics (16, 80), Integrative Lifestyle Medicine for Chronic Disease (12, 69), and Environmental Exposures and Metabolic Health (14, 48). The top five papers account for 46% of citations. Median citations per paper is 4.5, and 16 papers have at least 10 citations. Halma is first author on 57% of indexed works, with 9 solo publications, and has collaborated with 91 coauthors across 37 institutions. Frequent coauthors include Joseph Varón (34 works) and Paul Ellis Marik (11). The portfolio is 94% open access. Citing works originate from 71 countries, led by China (100) and the United States (91). Self-citation stands at 9%.

57%
First author
of 83 indexed works
13%
Last author
9 single-author
91
Co-authors
at 37 institutions
3.8
Authors per paper
mean
94%
Open access
78 of 83 works
15
Co-author countries
United States, Estonia, Canada
050100150200250Citations2019202120222023202420252026
Citations to date by year of publication (Google Scholar list).
051015Papers2019202120222023202420252026
Papers published per year (Google Scholar list).
Citation distributionValue
Papers listed44
Mean citations per paper12.7
Median citations per paper4.5
Papers with 10+ / 50+ / 100+ citations16 / 2 / 0
Share of citations in the h-core (top 14 papers)82%
Share of citations in the top five papers46%
Concentration (Gini, 0 even to 1 single paper)0.64
Papers from the last five years41 (451 citations)
Uncited papers6
Frequent co-authorsJoint works
Joseph Varón34
Paul Ellis Marik11
Gijs J. L. Wuite11
Jack A. Tuszyński9
Longfu Xu8
Edgar Selem8
Most frequent venuesPapersCitations
Biophysical Journal33
Nutrients173
Proceedings of the National Academy of Sciences172
Viruses147
Physical Review Letters135
MDPI BioMed128

OpenAlex document types: article 37 · review 22 · preprint 17 · dataset 4 · book-chapter 1.

7. Outlook: five-year projections

Projections based on recent citation trends suggest Halma’s h-index will reach 15 by 2027 and 20 by 2029, while total citations may rise to 1,187 in three years and 1,445 in five years. The i10-index is projected to reach 27 within three years. These estimates assume that current publication and citation patterns continue and do not account for shifts in research focus or field dynamics. The underlying model extrapolates from one year of observed growth, which may not capture longer-term variability.

05001,0001,500202020222024202620282030Cumulative citationsObservedProjected
Cumulative citations, observed year-end totals (solid) and model projection (dashed).
0102030202620272028202920302031Index valueh-index (projected)i10-index (projected)
Projected h-index and i10-index at each year-end, anchored at today's values.
Year-endh-indexi10-indexTotal citations
2026 (current)1416558
20271726761
20281827945
202921271,098
203023271,228
203123271,337

8. Publications: the 25 most-cited papers with forecasts

#TitleVenueYearCitationsPer year+1 yr+3 yr+5 yr
1Cancer Metabolism as a Therapeutic Target and Review of Interventions doi
MTJ Halma, JA Tuszynski, PE Marik
Nutrients 15 (19), 4225, 202320237321.995133161
2Complex dynamics under tension in a high-efficiency frameshift stimulatory structure doi
MTJ Halma, DB Ritchie, TR Cappellano, K Neupane, MT Woodside
Proceedings of the National Academy of Sciences 116 (39), 19500-19505, 20192019729.8778591
3Identifying inhibitors of− 1 programmed ribosomal frameshifting in a broad spectrum of coronaviruses doi
S Munshi, K Neupane, SM Ileperuma, MTJ Halma, JA Kelly, CF Halpern, ...
Viruses 14 (2), 177, 202220224710.8556776
4Conformational Shannon Entropy of mRNA Structures from Force Spectroscopy Measurements Predicts the Efficiency of Programmed Ribosomal Frameshift … doi
MTJ Halma, DB Ritchie, MT Woodside
Physical Review Letters 126 (3), 038102, 20212021356.6394448
5The novelty of mRNA viral vaccines and potential harms: a scoping review doi
MTJ Halma, J Rose, T Lawrie
J 6 (2), 220-235, 20232023298.7364653
6Public Health Needs the Public Trust: A Pandemic Retrospective doi
M Halma, J Guetzkow
MDPI BioMed 3 (2), 256-271, 20232023288.4344451
7Optical tweezers for drug discovery doi
MTJ Halma, JA Tuszynski, GJL Wuite
Drug Discovery Today 28 (1), 103443, 20232023288.4344451
8Strategies for the management of spike protein-related pathology doi
MTJ Halma, C Plothe, P Marik, TA Lawrie
Microorganisms 11 (5), 1308, 20232023267.8324147
9Unravelling how single-stranded DNA binding protein coordinates DNA metabolism using single-molecule approaches doi
L Xu, MTJ Halma, GJL Wuite
International Journal of Molecular Sciences 24 (3), 2806, 20232023267.8324147
10Mitochondrial Reactive Oxygen Species: A Unifying Mechanism in Long COVID and Spike Protein-Associated Injury: A Narrative Review doi
E Lee, AA Ozigbo, J Varon, M Halma, M Laezzo, SP Ang, J Iglesias
Biomolecules 15 (1339), 1-29, 2025202524185099138
11Graphene-based Nanomaterials: Uses, Environmental Fate, and Human Health Hazards doi
H du Preez, M Halma
Nano Biomedicine and Engineering 16 (2), 219-231, 202420242410.3344959
12Therapeutic Potential of Compounds Targeting SARS-CoV-2 Helicase doi
M Halma, M Wever, S Abeln, D Roche, G Wuite
Frontiers in Chemistry, 20222022173.9192225
13Mapping fast DNA polymerase exchange during replication doi
L Xu, M Halma, G Wuite
Nature Communications 15 (5328), 1-11, 20242024166.9223036
14Exploring autophagy in treating SARS-CoV-2 spike protein-related pathology doi
MTJ Halma, PE Marik, YM Saleeby
Endocrine and Metabolic Science, 20242024146192631
15Breaking the silence: Recognizing post-vaccination syndrome doi
M Halma, J Varon
Heliyon 11 (11), 20252025107.5193140
16Regulation of T7 gp2. 5 binding dynamics by its C-terminal tail, template conformation and sequence doi
L Xu, J Cabanas-Danés, MTJ Halma, I Heller, SA Stratmann, ...
Nucleic acids research 51 (13), 6540-6553, 20232023103121416
17Fiat Lux: Light and Pedagogy for the 21st Century doi
JC Lech, MTJ Halma, AO Obajuluwa, M Baker, MR Hamblin
Annals of Neurosciences, 2023202392.7111314
18Lifestyle medicine for healthy cognitive aging: A narrative review doi
M Halma, P Marik, S Gazda, J Tuszynski
Brain Behavior and Immunity Integrative, 2024202483.4111416
19Restoring trust in vaccination: listening to patients and acknowledging Post-Acute COVID Vaccine Syndrome doi
M Halma, J Varon
Frontiers in Medicine 12, 1688170, 2025202575.2132026
20Reversing Decline in Aging Muscles: Expected Trends, Impacts and Remedies doi
M Halma, P Marik, J Varon, J Tuszynski
Journal of Functional Morphology and Kinesiology 10 (1), 29, 2025202575.2132026
21The Search for Potential Remediation Strategies and Sustainable Alternatives for Safe use of US EPA Superfund Sites doi
AN Donald, BL Sanders, M Halma
Trends in Ecological and Indoor Environmental Engineering 1 (3), 11-24, 2025202553.791417
22Life under tension: the relevance of force on biological polymers doi
HM T.J., L Xu
Biophysics Reports, 2024202452.17910
23Overview of the Most Common Endocrine Disruptors: Exposure, Mechanism, Health Effects, and Remediation Strategies doi
C Gracidas, E Selem, ND Anyiam, B Fertig, J Varon, M Halma
Environmental Toxicology, 1-41, 2026202648215378
24Acute Management of Measles: A Systematic Review of Therapeutic Strategies doi
A Kaur, U Alaribe, J Varon, S Hassaan, M Halma
Antiviral Research, 2026202648215378
25The persistence of COVID-19 vaccine artifacts in bodily fluids and tissues: a systematic review doi
E Selem, M Raszek, J Varon, M Halma
Future Journal of Pharmaceutical Sciences 12 (16), 1-22, 2026202636153550

Forecasts follow each paper's own fitted citation curve (see appendix). 6 listed papers have no citations yet and are forecast at zero.

9. Research themes

The 83 works with abstracts in OpenAlex were clustered by the vocabulary of their titles and abstracts into 5 themes, which the model then named and connected. The share column is each theme's share of OpenAlex citations to those works.

ThemePapersYearsCitationsShare
mRNA Vaccine Frameshifting and Public Trust
Investigate programmed ribosomal frameshifting in coronaviruses, the novelty and potential harms of mRNA vaccines, and the erosion of public trust during the pandemic.
e.g. Identifying Inhibitors of −1 Programmed Ribosomal Frameshifting in a Broad Spectrum of Coronaviruses; The Novelty of mRNA Viral Vaccines and Potential Harms: A Scoping Review
262021–202613730%
Force Spectroscopy of DNA-Protein Interactions
Use optical tweezers to probe tension-dependent dynamics of nucleic acids and proteins, including replication, frameshift stimulation, and measles therapeutics.
e.g. Complex dynamics under tension in a high-efficiency frameshift stimulatory structure; Optical tweezers for drug discovery
152019–202612127%
Spike Protein Injury and Therapeutics
Target spike protein-related pathology through mitochondrial antioxidants, autophagy, and herbal compounds in long COVID and vaccine injury.
e.g. Strategies for the Management of Spike Protein-Related Pathology; Mitochondrial Reactive Oxygen Species: A Unifying Mechanism in Long COVID and Spike Protein-Associated Injury: A Narrative Review
162022–20268018%
Integrative Lifestyle Medicine for Chronic Disease
Apply lifestyle and integrative medicine approaches to cancer, depression, and COPD, emphasizing metabolic and dietary interventions.
e.g. Cancer Metabolism as a Therapeutic Target and Review of Interventions; Lifestyle medicine for healthy cognitive aging: A narrative review
122014–20266915%
Environmental Exposures and Metabolic Health
Assess hazards from nanomaterials and endocrine disruptors, and explore metabolic modulation for post-vaccination syndrome.
e.g. Graphene-based Nanomaterials: Uses, Environmental Fate, and Human Health Hazards; Fiat Lux: Light and Pedagogy for the 21st Century
142019–20264811%
0102030Papers20142019202120222023202420252026mRNA Vaccine Frameshifting and Public…Force Spectroscopy of DNA-Protein Int…Spike Protein Injury and TherapeuticsIntegrative Lifestyle Medicine for Ch…Environmental Exposures and Metabolic…
Papers per year by theme.

What connects the themes

Underlying Halma's work is a mechanistic curiosity about how molecular structures—particularly nucleic acids under force—govern biological function and how their perturbation by exogenous agents (vaccines, spike protein, environmental toxins) leads to disease. The recurring question is how tension-dependent conformational changes, from frameshift stimulatory RNA pseudoknots to DNA polymerase exchange, become dysregulated and how that dysregulation might be remedied. Single-molecule optical tweezers serve as a core method for revealing these dynamics, while systematic and narrative reviews extend that mechanistic thinking to population-level harms and interventions. Shared objects include the SARS-CoV-2 spike protein, mRNA vaccine constructs, and metabolic pathways as targets. An intellectual commitment to critiquing established vaccine narratives and seeking accessible, integrative therapies—herbals, lifestyle changes, repurposed drugs like ivermectin—ties these themes together, moving from biophysical entropy measurements to real-world concerns about public trust, post-vaccination syndromes, and environmental health.

How the work developed

Early work (2019–2021) centered on single-molecule biophysics of frameshift sequences and DNA-binding proteins under tension. The pandemic prompted a pivot: 2022 papers addressed coronaviral frameshifting inhibitors and mRNA vaccine novelty, while 2023 publications tackled spike protein pathology and public health trust. From 2024 onward, the scope broadened into lifestyle medicine for chronic diseases, environmental toxicology, and the long-term sequelae of vaccination, with 2025–2026 outputs on post-acute vaccination syndrome, vaccine artifact persistence, and metabolic modulation strategies.

OpenAlex author A5078697129 · ORCID 0000-0003-2487-0636 · 83 works indexed · 457 citations in OpenAlex. OpenAlex topic labels: SARS-CoV-2 and COVID-19 Research · 21 Force Microscopy Techniques and Applications · 18 RNA and protein synthesis mechanisms · 13 Long-Term Effects of COVID-19 · 11 COVID-19 Clinical Research Studies · 10

10. Observation log

DateSourceCitationsh-indexi10-index
October 30, 2026Google Scholar (live)5581416
October 20, 2026Wayback Machine5521316
October 13, 2025Wayback Machine3291111

Part II. Opportunities

Leads generated from the researcher's record on the day of the report. They date quickly; the dashboard's researcher tools refresh them daily.

11. Collaborators to contact

Active authors in the researcher's topics (SARS-CoV-2 and COVID-19 Research, Force Microscopy Techniques and Applications, RNA and protein synthesis mechanisms) who have never co-authored with them, ranked by similarity between their recent abstracts and this researcher's. Each line gives the reason the work connects. These are leads for outreach, not endorsements.

AuthorInstitutionOverlapWhy it connects
Ziyad Al‐Aly
11 recent papers in shared topics, e.g. Long COVID science, research and policy (2024)
Washington University in St. Louis37%Your work on long COVID epidemiology and risk quantification is relevant to Matthew Thomas J Halma's work on mitochondrial reactive oxygen species as a unifying mechanism in long COVID because both address the need to characterize long COVID burden and underlying drivers.
David F. Putrino
5 recent papers in shared topics, e.g. Distinguishing features of long COVID identified through immune profiling (2023)
Icahn School of Medicine at Mount Sinai36%Your work on immune profiling to distinguish long COVID features is relevant to Matthew Thomas J Halma's work on spike protein-related pathology because both investigate host factors and pathophysiological mechanisms underlying post-acute sequelae.
Yan Xie
9 recent papers in shared topics, e.g. Postacute sequelae of COVID-19 at 2 years (2023)
VA St. Louis Health Care System36%Your work on postacute sequelae of COVID-19 at 2 years is relevant to Matthew Thomas J Halma's work on long COVID mitochondrial mechanisms because both contribute to defining the long-term health impacts and risk profiles of SARS-CoV-2 infection.
Timothy J. Henrich
7 recent papers in shared topics, e.g. Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2 (2024)
University of California, San Francisco33%Your work on T cell dysregulation and inflammation in long COVID is relevant to Matthew Thomas J Halma's work on mitochondrial reactive oxygen species in long COVID because both explore how immune and inflammatory damage contribute to persistent symptoms.
Taeyoung Choi
5 recent papers in shared topics, e.g. Association of Treatment With Nirmatrelvir and the Risk of Post–COVID-19 Condition (2023)
VA St. Louis Health Care System31%Your work on nirmatrelvir and risk of post-COVID-19 condition is relevant to Matthew Thomas J Halma's work on strategies for managing spike protein-related pathology because both address interventions to reduce long-term COVID-19 complications.
Steven G. Deeks
7 recent papers in shared topics, e.g. Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2 (2024)
University of California, San Francisco28%Your work on inflammation and immune dysregulation in long COVID is relevant to Matthew Thomas J Halma's work on mitochondrial dysfunction in long COVID because both examine how infection-associated inflammation drives chronic disability.
Hannah Davis
6 recent papers in shared topics, e.g. Long COVID: major findings, mechanisms and recommendations (2023)
Patient-Led Research Collaborative27%Your work on long COVID mechanisms and recommendations is relevant to Matthew Thomas J Halma's work on public health trust during the pandemic because both engage with policy implications and the need for patient-centered research frameworks.
Lisa McCorkell
7 recent papers in shared topics, e.g. Long COVID: major findings, mechanisms and recommendations (2023)
Patient-Led Research Collaborative23%Your work on defining long COVID and postacute sequelae is relevant to Matthew Thomas J Halma's work on spike protein-related pathology because both seek to clarify the definition and mechanisms of post-COVID conditions for better management.

12. Grants that fit

Open and forecasted calls on Grants.gov, searched on mrna, vaccine, vaccines, dna, SARS-CoV-2 and COVID-19 Research, Force Microscopy Techniques and Applications and scored against the researcher's abstracts (fingerprint: mRNA Vaccine Frameshifting and Public Trust; Force Spectroscopy of DNA-Protein Interactions; Spike Protein Injury and Therapeutics; Integrative Lifestyle Medicine for Chronic Disease; Environmental Exposures and Metabolic Health). Grants.gov was not serving call descriptions when this report was built, so open-call fit is scored on titles only and runs low. Recently funded NIH and NSF projects like this researcher's show where similar work is being funded now.

Open or forecasted callAgencyClosesFit
Assessing the Feasibility of Incorporating Mechanisms in Multi-site Clinical Trials of Mind and Body Interventions on Whole Person Health Restoration (R33 Clinical Trial Required)
This fits Halma's work on integrative lifestyle medicine for chronic disease, as they could propose a mind-body intervention trial assessing mechanisms of whole person health restoration, though the clinical trial requirement may be a hurdle given their focus on molecular mechanisms and public trust.
HHS-NIH1111/16/202914%
Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional)
This does not fit Halma's research profile, as they have no demonstrated work in HIV prevention, treatment, or care, and their expertise in mRNA vaccines, spike protein injury, and lifestyle medicine does not align with implementation science for HIV.
HHS-NIH1106/20/202912%
Resource-Related Research Projects for Development of Models and Related Materials for Studying Human Health and Diseases (R24 Clinical Trials Not Allowed)
This fits Halma's work on force spectroscopy of DNA-protein interactions and spike protein injury, as they could propose developing new models or materials for studying protein-DNA mechanics relevant to disease mechanisms, though the resource-development focus is a partial mismatch with their mechanistic research.
HHS-NIH1109/28/202812%
HEAL Initiative: Integrative Management of Chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required)
This fits Halma's integrative lifestyle medicine focus, as they could propose a research center on integrative management of chronic pain and opioid use disorder using lifestyle and mind-body approaches, though the clinical trial requirement and RM1 center scope may exceed their current research infrastructure.
HHS-NIH1101/26/202711%
Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional)
This partially fits Halma's interest in environmental exposures and metabolic health, as they could propose investigating early-onset cancer etiology related to environmental toxins or metabolic dysfunction, though their published work does not directly address cancer biology or early detection.
HHS-NIH1110/11/202910%
Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
This does not fit Halma's research profile, as it is a single-source continuation for a specific acute kidney injury data center, and Halma has no demonstrated expertise in nephrology, acute kidney injury, or multi-site clinical trial data coordination.
HHS-NIH1111/09/202610%
Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)
This does not fit Halma's work, as their research on force spectroscopy and spike protein injury does not involve systematic characterization of genomic variation or functional genomics of individual variants, and the UM1 mechanism is for large-scale consortia.
HHS-NIH1112/14/202610%
NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01 Clinical Trial Not Allowed)
This does not fit Halma's research profile, as it is a biospecimen access mechanism for existing NIH cohort studies on brain development and tobacco health, and Halma's work does not involve population cohort studies or biospecimen-based epidemiology.
HHS-NIH1104/17/202910%
Recently funded project like this workFunderPI and organisationAmountFit
Evaluating SARS-CoV-2 spike antigen-induced coagulopathy and neuroinflammation as mechanistic drivers of neurologic PASCNINDS R01PELUSO, MICHAEL JOSEPH, UNIVERSITY OF CALIFORNIA, SAN FRANCISCO (2026)$638,18429%
Induction and maintenance of SARS-CoV-2 mRNA vaccine-specific memory across tissuesNIAID F30DAVIS-PORADA, JULIA MEGHAN, COLUMBIA UNIVERSITY HEALTH SCIENCES (2026)$55,11428%
The role of SARS-CoV-2-induced senescence in the development of Alzheimer's DiseaseNINDS R01MARKOUTSA, ELENI , UNIVERSITY OF SOUTH FLORIDA (2026)$369,82328%
Longitudinal SARS-CoV-2 mRNA vaccine-induced mucosal, serological, and cellular immunity in children and human milkNIAID R01PANNARAJ, PIA S, UNIVERSITY OF CALIFORNIA, SAN DIEGO (2026)$801,42227%
Emerging mechanisms of viral gene regulation from battles between host and SARS-CoV-2NIAID DP2LIU, CHANG , JOHNS HOPKINS UNIVERSITY (2026)$478,76127%
Implementation of a qPCR-based assay for the quantification of SARS-CoV-2-specific T cells in immunocompromised patientsNCI UH3OCHANDO, JORDI , ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (2026)$350,35827%

13. Open positions in the field

Faculty, fellowship and postdoctoral openings posted in the last five months on Chronicle of Higher Education, Times Higher Education, jobRxiv, searched on Biophysics, Infectious Diseases, Atomic Molecular Physics Optics, Molecular Biology, Neurology and ranked by fit with the researcher's field and publication titles (248 postings considered). Postings close quickly; follow the link for the current status.

PositionRankInstitution and locationPostedFit
PhD fellowship in Protein Dynamics at the Department of Drug Design and Pharmacology
matches: protein, drug, dynamics, possible
Fellowship—2026-10-0731%
Health Sciences Assistant or Associate Clinical Professor of Neurology
matches: neurology, health, clinical, overview
Faculty—2026-10-0630%
Associate Professor in Biochemistry and Molecular Biology, Synthetic Biology, and Metabolic
matches: metabolic, biochemistry, biology, molecular
FacultyUniversity of Georgia2026-10-1528%
PhD fellowship in Biological Physics
matches: physics, biological, dynamics, protein
Fellowship—2026-09-2227%
Pediatrics – Infectious Diseases Health Sciences Assistant Clinical Professor
matches: health, clinical, infectious, diseases
Faculty—2026-09-0427%
Seeking a few Postdoctoral Researchers (26-1710)
matches: rna, dna, protein, biochemistry
Postdoc / research staff—2026-10-2825%
Department of Laboratory Medicine/Microbiology Faculty Position at the San Francisco VA Health Care System
matches: care, health, medicine, pathology
Faculty—2026-10-0325%
Assistant Professor of Biology(Genetics, Molecular Biology)
matches: genetics, biology, molecular
FacultyKing's College
Wilkes Barre, Pennsylvania
2026-09-3025%
Assistant Professor of Experimental Physics (with research expertise in optics/quantum optics)
matches: optics, physics
FacultyCalifornia State University, Fullerton
California, United States
2026-09-2825%
Infectious Diseases Clinical Faculty
matches: infectious, diseases, clinical
FacultyUniversity of Utah2026-09-1425%

Appendix: methods and sources

Live figures are read from the public Google Scholar profile on October 31, 2026. Google Scholar counts citations from a broader set of sources than Web of Science, Scopus or OpenAlex, so its totals run higher.

Trajectory and milestones: every archived copy of the profile in the Internet Archive's Wayback Machine was parsed for total citations, h-index and i10-index (2 usable captures from 2 archived copies), and combined with CiteVector's own dated observations. Each point is the value Google Scholar displayed on that date. A milestone is dated to the first observation at or above the level, so the true date lies between that observation and the one before it.

Projections use the citation model of Wang, Song and Barabási (Science 342, 127, 2013), equation 3: c(t) = m(eλΦ((ln t − μ)/σ) − 1), with m = 30, Φ the standard normal CDF, impact time T* = eμ fixed at 3 years and σ = 1.2 (the paper's reported typical values). The fitness λ of each paper is solved from its observed citation count and age; future counts follow the same curve. Publication dates are taken as mid-year, and a paper published in the current year is assumed to be six months old so that its fitness is not solved at an age where Φ is close to zero. The h-index and i10-index are recomputed from the projected per-paper counts at each year-end and anchored to today's actual values. The model does not include papers not yet published, so it is conservative for active researchers, and it treats each paper independently.

Research themes are found by clustering the titles and abstracts of the researcher's OpenAlex works (TF-IDF vectors, cosine k-means, the number of themes chosen by a silhouette-type score between 3 and 6); words that describe a paper's genre rather than its subject are removed first. The themes are then named and connected in prose by a language model from the cluster terms, paper titles and the vocabulary shared between clusters. Clustering is unsupervised: a paper sits in exactly one theme, and borderline papers can land in either of two related themes.

Research topics, authorship and open access come from OpenAlex's author record where a confident match (name, affiliation and paper titles) exists. Authorship position is the order OpenAlex lists authors; the first- and last-author shares exclude single-author works from the position counts but include them in the total. Open-access share counts works OpenAlex marks as open access in any form (gold, green, hybrid, bronze).

Citation reach counts every OpenAlex work citing any of the researcher's 50 most-cited works, grouped by the countries and institutions of the citing authors (a paper counts once per distinct country or institution), by venue and by year. Independent citations are citing works that do not list the researcher as an author.

Peer percentiles are exact counts, not samples: OpenAlex is asked how many authors in the same topic (and, for the second group, the same works band) exist, and how many of them have a lower h-index (or fewer citations) than this researcher. Ties count as not below. The works band is the only career-stage control OpenAlex allows for peers (it does not expose a first-publication year), and because OpenAlex counts preprints and versions it tends to compare the researcher with more senior authors; the active-author group has no such bias but mixes career stages. Percentiles depend on the topic chosen, so up to three topics are shown. Self-citation share is the fraction of papers citing the researcher's most-cited works that list the researcher as an author, computed from OpenAlex authorships.

Opportunities (collaborators, grants, positions) are generated from public sources on the day of the report: OpenAlex for authors active in the same topics, Grants.gov, NIH RePORTER and NSF for calls and funded projects, and the Chronicle of Higher Education, Times Higher Education and jobRxiv feeds for openings. Fit scores are TF-IDF cosine similarities between the researcher's abstracts (or field terms, for positions) and each item, scaled to 0–100; they rank candidates and are not probabilities.

Citation distribution: the Gini coefficient is computed over the citation counts of all listed papers; the h-core is the 14 papers that define the h-index.

Report generated by CiteVector (citevector.xyz) on October 31, 2026 for the purchaser · sample. Figures are reproduced as displayed by the sources named above; CiteVector does not alter them.